clinicaltrialsarena11h
FDA clears SpliceBio’s IND application to begin Stargardt disease therapy trial
The US FDA has granted clearance to SpliceBio’s IND application to begin the trial of SB-007, designed for Stargardt disease treatment.
clinicaltrialsarena17h
WHO trial guidance goes beyond race and gender when tackling diversity
The WHO’s guidance provides direction on diversity and how to include patients who are pregnant, lactating and from low-middle income countries.
clinicaltrialsarena10h
DREAM-HF trial sheds positive light on Revascor for ischemic HF
Mesoblast Limited recently announced positive Phase III trial results in the European Journal of Heart Failure.
clinicaltrialsarena15h
Trevi’s chronic cough trial in IPF subjects continues without sample size change
Trevi has announced that its Phase IIb trial of Haduvio in treating IPF subjects with chronic cough will continue without sample size change.
clinicaltrialsarena16h
SK bioscience gains approval in Australia to begin trials of mRNA-based vaccine
SK bioscience has gained Australia’s Human Research Ethics Committee (HREC) approval to begin Phase I/II clinical trials of GBP560.